Oxfam: COVID-19 vaccinations for vulnerable could cost fraction of top pharma’s yearly profits

By |maj 14th, 2020|coronavirus, coronavirus research, coronavirus vaccine, COVID-19, News, Oxfam, vaccines|

Oxfam is urging governments and pharmaceutical companies to guarantee that vaccines, tests, and treatments will be patent-free and equitably distributed to all nations and people, ahead of the World Health Assembly next week.

Komentarji so izklopljeni za Oxfam: COVID-19 vaccinations for vulnerable could cost fraction of top pharma’s yearly profits

Europe pins hopes on antibody tests to avoid second virus wave

By |maj 14th, 2020|coronavirus research, News|

As Europe gingerly eases its coronavirus lockdowns, many governments are scrambling to buy antibody tests to find out how many of their citizens were infected, in the hope that will help them craft strategies to avoid a second wave of COVID-19 cases.

Komentarji so izklopljeni za Europe pins hopes on antibody tests to avoid second virus wave